Leuschner U, Wurbs D, Baumgärtel H, Helm E B, Classen M
Scand J Gastroenterol. 1981;16(4):497-503. doi: 10.3109/00365528109182004.
Twenty patients with bile duct stones were treated via an indwelling nasobiliary tube with a modified Capmul 8210 preparation (GMOC) and alternating with a bile salt-EDTA (BA-EDTA) solution for an average of 12 days. In vitro the dissolution capacity of GMOC and BA-EDTA for cholesterol stones was higher than that of Capmul 8210. The nasobiliary tube was tolerated well for a maximum of 84 days; this renders us independent of the T-tube. The therapeutic success rate of GMOC was 64%, even though we treated mostly old and large concrements. Side effects occurred markedly less than with Capmul 8210. In patients with acute cholecystitis or cholangitis the clinical course improved under therapy, and there was no deterioration of a chronic condition.
20例胆管结石患者通过留置鼻胆管,使用改良的Capmul 8210制剂(GMOC)并交替使用胆盐-乙二胺四乙酸(BA-EDTA)溶液进行治疗,平均治疗12天。在体外,GMOC和BA-EDTA对胆固醇结石的溶解能力高于Capmul 8210。鼻胆管最多可耐受84天;这使我们无需使用T形管。GMOC的治疗成功率为64%,尽管我们治疗的大多是陈旧性大结石。副作用的发生明显少于使用Capmul 8210时。在急性胆囊炎或胆管炎患者中,治疗期间临床病程有所改善,慢性病况也未恶化。